Table 2.
Glucose Uptake | Glucose Analog Used | Cell Type | Reference |
---|---|---|---|
inhibit (in vivo) | 2-deoxy-2-[18F]fludeoxyglucose ([18F]FDG) uptake |
A2780, SKOV3 (injected in female nu/nu mice). | [166] |
inhibit (in vivo) | 2-deoxy-2-[18F]fludeoxyglucose ([18F]FDG) uptake |
LLC (injected in BALB/c-n mice) | [151] |
inhibit (in vitro) | 3-O-methyl-D-glucose (OMG) or 2-deoxy glucose (2-DG) uptake | HL60, U937, RBC | [116] |
inhibit (in vitro) | (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose) (2-NBDG) uptake | PA-1, OVCAR3, MDAH2774 | [147] |
inhibit (in vitro) | [3H]-2-DG uptake | A2780, MDAH-2774, HOC-1, HOC-8, OVCA 429, and OVCA 432 SKOV3 | [117] |
inhibit (in vitro) | Glucose Oxidase Assay Kit | A2780, SKOV3 | [119] |
Increase (in vitro) | 2-deoxy-D-[3H] glucose uptake | 3T3-L1 | [120] |
Inhibit (in vitro) | Glucose (hexokinase) assay kit | HUVEC | [149] |
inhibit (in vitro) | (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose) (2-NBDG) uptake | Neuro-2a (N2A) | [121] |
Increase (in vitro) | 2-doxy-D-glucose (2DG) | L6 | [167] |
Increase (in vitro) | [3H] DG | BeWo | [168] |
Increase (in vitro) | 2-deoxy-D-glucose (2DG) | Placental lobules | [150] |